Effects of Valiltramiprosate on Plasma P-tau217 and Select Pro-Inflammatory and Vascular Injury Biomarkers with the NULISA CNS Panel: Exploratory Analyses from the Phase 3 APOLLOE4 Trial in APOE4/4 Homozygotes with Early AD

valiltramiprosate (ALZ-801) - Alzheon

https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/Poster-list_July7.pdf

Susan ABUSHAKRA 1; John A HEY 1; F. ELAHI 2; David WATSON 3; Aidan POWER 1; Marwan SABBAGH 4; Sharon COHEN 5; Earvin LIANG 6; E. HRISTOVA 6; J. Patrick KESSLAK 6; Susan FLINT 6; Adem ALBAYRAK 6; Martin TOLAR 6

Aug 3, 2026